Platform Technology Partners Vbi Vaccines Inc Transaction History

Platform Technology Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$2.15 - $3.5 $25,370 - $41,300	-11,800 Closed	0 $0
Q3 2020 Nov 30, 2020	SELL	$2.77 - $6.17 $50,691 - $112,911	-18,300 Reduced 60.8%	11,800 $34,000
Q2 2020 Nov 30, 2020	BUY	$0.87 - $3.13 $5,655 - $20,345	6,500 Added 27.54%	30,100 $93,000
Q1 2020 Nov 30, 2020	SELL	$0.73 - $1.91 $41,537 - $108,679	-56,900 Reduced 70.68%	23,600 $22,000
Q4 2019 Dec 03, 2020	BUY	$0.48 - $1.38 $38,640 - $111,089	80,500 New	80,500 $111,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Platform Technology Partners, based on Form 13F filings with the SEC.

Stay updated on Platform Technology Partners with notifications on news.